HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glutathione S-transferase M1 polymorphism and colorectal cancer risk in Chinese population.

Abstract
Glutathione S-transferase M1 (GSTM1) polymorphism has been proven to be associated with risks of several cancers. However, previous studies on the association between GSTM1 polymorphism and colorectal cancer risk in Chinese population reported controversial results. We performed a meta-analysis of 13 studies which were identified through the literature search in PubMed and Wanfang databases. The strength of the association between GSTM1 polymorphism and colorectal cancer risk was measured by odds ratio (OR) with corresponding 95% confidence interval (95% CI). Overall, GSTM1 null mutation was significantly associated with a risk of colorectal cancer in Chinese population (OR = 1.37, 95% CI 1.12 to 1.68, P = 0.002). Sensitivity analyses by omitting those studies in turns did not materially alter the overall pooled ORs. The cumulative meta-analyses further showed a trend of an obvious association between GSTM1 null mutation and risk of colorectal cancer in Chinese population as information accumulated by year. The findings from our meta-analysis suggest that GSTM1 null mutation is significantly associated with a risk of colorectal cancer in Chinese population.
AuthorsZan Teng, Lei Wang, Jingdong Zhang, Shuang Cai, Yunpeng Liu
JournalTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (Tumour Biol) Vol. 35 Issue 3 Pg. 2117-21 (Mar 2014) ISSN: 1423-0380 [Electronic] Netherlands
PMID24197978 (Publication Type: Journal Article, Meta-Analysis)
Chemical References
  • Glutathione Transferase
  • glutathione S-transferase M1
Topics
  • Asian People (genetics)
  • Colorectal Neoplasms (genetics)
  • Genetic Predisposition to Disease (genetics)
  • Glutathione Transferase (genetics)
  • Humans
  • Odds Ratio
  • Polymorphism, Genetic (genetics)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: